Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria - clinical implications, G.L. Warwick and C.J. Packard; proteinuria, hyperlipidemia, and the kidney, F.N. Hutchison; relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus, W.G. Walker; intraglomerular lipid deposition in renal disease, H.S. Lee and S.K. Lee; interactions between lipoproteins, glomerular cells and matrix, D.C. Wheeler and R.S. Chana; renal hemodynamic consequences of hyperlipidemia, N. Bank; the mevalonate pathway - importance in mesangial cell biology and glomerular disease, M.P. O'Donnell et al; lipid abnormalities and end stage renal disease - implications for atherosclerotic cardiovascular disease?, M.D. Cressman et al; risk factors for cardiovascular disease after renal transplantation, B.L. Kasiske; treatment of hyperlipidemia in human renal disease, G. D'Amico and M.G. Gentile.
